Zacks Investment Research on MSN

LH Shares Gain Following Publication of New Plasma Detect MRD Data

Labcorp LH recently announced that the Labcorp Plasma Detect was featured in two recent peer-reviewed publications – Nature Medicine and Clinical Cancer Research. Labcorp Plasma Detect is a ...
The Malaysian Reserve

Labcorp® Plasma Detect™ Clinical Studies Featured in Nature Medicine and Clinical Cancer Research

Studies demonstrate Labcorp Plasma Detect MRD Technology can inform treatment strategies and advance cancer research BURLINGTON, N.C., ...
Le Lézard

Labcorp® Plasma Detecttm Clinical Studies Featured in Nature Medicine and Clinical Cancer Research

Labcorp , a global leader of innovative and comprehensive laboratory services, today announced Labcorp Plasma Detect, a tumor-informed, blood-based assay used to detect molecular residual disease (MRD ...

European Commission Approves Subcutaneous Administration of KEYTRUDA® (pembrolizumab) for All Adult Indications Approved in the European Union

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the European Commission (EC) ...